Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Cyanotech Corporation (CYAN)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
03/24/2025: CYAN (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -46.04% | Avg. Invested days 23 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 03/24/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 2.94M USD | Price to earnings Ratio - | 1Y Target Price 14 |
Price to earnings Ratio - | 1Y Target Price 14 | ||
Volume (30-day avg) 2951 | Beta 0.03 | 52 Weeks Range 0.26 - 0.89 | Updated Date 03/30/2025 |
52 Weeks Range 0.26 - 0.89 | Updated Date 03/30/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.75 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -9.84% | Return on Equity (TTM) -39.69% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 13793981 | Price to Sales(TTM) 0.1 |
Enterprise Value 13793981 | Price to Sales(TTM) 0.1 | ||
Enterprise Value to Revenue 0.58 | Enterprise Value to EBITDA 21.94 | Shares Outstanding 7155860 | Shares Floating 4602568 |
Shares Outstanding 7155860 | Shares Floating 4602568 | ||
Percent Insiders 38.27 | Percent Institutions - |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Cyanotech Corporation
Company Overview
History and Background
Cyanotech Corporation, founded in 1983, is a world leader in microalgae-based nutrition. They specialize in cultivating microalgae to produce high-value nutritional and health products. Initially focused on biofuels, they shifted to nutritional products in the late 1990s.
Core Business Areas
- Human Nutrition: Production and sale of nutritional supplements derived from microalgae, including spirulina and astaxanthin, marketed under brands like Nutrex Hawaii.
- Animal Nutrition: Development and sale of astaxanthin-based feed ingredients for aquaculture and animal health.
- Contract Manufacturing: Manufacturing of microalgae-based products for other companies under private label agreements.
Leadership and Structure
Cyanotech is led by Gerry Cysewski (CEO). The company operates with a functional organizational structure, with departments for research and development, production, sales, and marketing.
Top Products and Market Share
Key Offerings
- BioAstin Hawaiian Astaxanthin: A natural antioxidant derived from Haematococcus pluvialis microalgae. Used to support joint, skin, and eye health. Competitors include AstaReal (Fuji Chemical), Algatechnologies, and Valensa International. Market share data specific to BioAstin is not publicly available, but the overall astaxanthin market is competitive. The global astaxanthin market is projected to reach $1.7 billion by 2028.
- Hawaiian Spirulina Pacifica: A nutrient-rich blue-green algae. Used as a dietary supplement for overall health and energy. Competitors include Earthrise Nutritionals (DIC Corporation) and NOW Foods. Market share data specific to Hawaiian Spirulina Pacifica is not publicly available. The global spirulina market is projected to reach $825 million by 2028.
Market Dynamics
Industry Overview
The nutraceuticals industry is experiencing significant growth, driven by increasing consumer awareness of health and wellness. Demand for natural and sustainable ingredients is rising.
Positioning
Cyanotech is positioned as a premium supplier of microalgae-based nutritional products, emphasizing its Hawaiian origin, quality control, and scientific research. They have competitive advantages in their farming location and technology.
Total Addressable Market (TAM)
The combined TAM of astaxanthin and spirulina markets is significant, projected to exceed $2.5 billion by 2028. Cyanotech is positioned to capture a share of this growing market, focusing on high-quality production and premium branding.
Upturn SWOT Analysis
Strengths
- Strong brand recognition (Nutrex Hawaii)
- Vertical integration (cultivation to finished product)
- Hawaiian origin and sustainability story
- High-quality product standards
- Established distribution channels
Weaknesses
- Limited product diversification
- Reliance on two key products (spirulina and astaxanthin)
- Vulnerability to weather-related production disruptions
- Higher price point compared to some competitors
- Dependence on online sales
Opportunities
- Expanding into new geographic markets
- Developing new microalgae-based products
- Increasing demand for plant-based protein
- Partnerships with food and beverage companies
- Growing awareness of preventative health
Threats
- Competition from lower-priced suppliers
- Changing regulatory landscape for dietary supplements
- Price fluctuations in raw materials
- Adverse weather conditions impacting harvests
- Negative publicity related to algae blooms
Competitors and Market Share
Key Competitors
- DIC Corporation (6316.T)
- Fuji Chemical Industry Co., Ltd.(4996.T)
- DSM(DSM.AS)
Competitive Landscape
Cyanotech competes in the nutraceuticals market, facing both large multinational corporations and smaller specialized companies. Cyanotech differentiates itself through its Hawaiian origin, quality standards, and focus on microalgae-based nutrition.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Cyanotech has experienced moderate revenue growth in recent years, driven by increased demand for its core products.
Future Projections: Analyst estimates suggest continued growth in the nutraceuticals market, which could benefit Cyanotech. Future projections depend on market conditions and the company's execution of its strategic initiatives. A positive future is expected due to the increase of wellness products
Recent Initiatives: Recent initiatives include expanding its online presence, developing new product formulations, and investing in sustainable farming practices.
Summary
Cyanotech is a niche player in the nutraceuticals market with strong branding and a focus on microalgae-based nutrition. Its Hawaiian origin and vertical integration are key strengths. The company needs to diversify its product line and manage weather-related risks to achieve sustainable growth. Overall, the company seems to have a strong foundation, but external factors can influence its stability.
Similar Companies
Sources and Disclaimers
Data Sources:
- Cyanotech Corporation Investor Relations
- Industry Reports (Nutraceuticals, Spirulina, Astaxanthin)
- Market Research Reports
- Company Press Releases
Disclaimers:
This analysis is based on publicly available information and is for informational purposes only. It is not financial advice. Market share data is estimated based on available information and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Cyanotech Corporation
Exchange NASDAQ | Headquaters Kailua-Kona, HI, United States | ||
IPO Launch date 1993-06-22 | President, CEO & Director Mr. Matthew Keith Custer | ||
Sector Consumer Defensive | Industry Packaged Foods | Full time employees 77 | Website https://www.cyanotech.com |
Full time employees 77 | Website https://www.cyanotech.com | ||
Cyanotech Corporation, an agricultural company, engages in the production of natural products derived from microalgae worldwide. The company offers BioAstin Hawaiian Astaxanthin, a natural antioxidant to enhance skin, and to support eye, joint and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement to support natural energy, immune system, and cardiovascular health, as well as a source of antioxidant carotenoids. It also provides contract extraction and research and development services. The company sells its products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors in the health food, cosmetic manufacturers and nutraceuticals, and dietary supplement markets. Cyanotech Corporation was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.